Showing 894 results

Filters Content type: News, Editors' picks Topic: Starting treatment

Everyone who has diagnosed HIV is recommended to take HIV treatment. It is better for your health to begin HIV treatment sooner, rather than later.

Starting treatment

Most used ARV regimen in South Africa may yield poorest survival

Editor's pick
International AIDS Society
7 January 2011
Side effects

Tenofovir with 3TC or FTC associated with lower lipid increases than other NRTI pairs

News
14 December 2010
Retention & linkage to care

Missed appointments in first six months of HIV treatment associated with poorer outcomes

News
13 December 2010
Starting treatment

Immediate HIV treatment has biggest impact in TB patients with CD4 counts below 100

News
30 November 2010
Starting treatment

Study confirms that the sooner treatment is started the better

News
9 November 2010
Adherence

One-pill regimen improves adherence and reduces hospitalisation in insured US patients

News
9 November 2010
Side effects

IDSA: No Race or Gender Safety Issues Observed in Studies (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
24 October 2010
Adherence

IDSA: Experienced Providers May Boost HIV Treatment Adherence (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
24 October 2010
Starting treatment

IDSA: Physicians Lag in Adopting Earlier Tx Initiation (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
23 October 2010
Cardiovascular disease

Drug safety bodies issue warning on heart rhythm risks with saquinavir (Invirase)

News
22 October 2010
Neurological & cognitive problems

Neurotune presents positive dimiracetam Phase IIa results for treatment of neuropathic pain in HIV-positive patients

Editor's pick
Pharmaceutical Business Review
22 October 2010
New & experimental HIV treatments

Shionogi-ViiV Healthcare begin two phase III studies for investigational once-daily HIV integrase inhibitor

Editor's pick
Market Watch
21 October 2010
Starting treatment

Gilead Profit Beats Forecasts on Jump in HIV Drug Sales

Editor's pick
CNBC
19 October 2010
Starting treatment

High long-term economic costs associated with late HIV diagnosis

News
27 September 2010
New & experimental HIV treatments

ICAAC: Novel HIV drug a 'trade-off'

Editor's pick
MedPage Today
17 September 2010
Drug interactions & pharmacokinetics

Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC

Editor's pick
Doctor's Guide
16 September 2010
New & experimental HIV treatments

Elvitegravir "Quad" single-tablet regimen shows continued HIV suppression at 48 weeks

Editor's pick
HIVandhepatitis.com
15 September 2010
Starting treatment

FDA Approves New Labeling For ISENTRESS® To Include 96-Week Efficacy And Tolerability Data In Adult Patients Infected With HIV-1

Editor's pick
Medical News Today
6 August 2010
Government, leadership & policy

Lymphocyte count and haemoglobin can predict prognosis of patients starting ART

News
3 August 2010
Neurological & cognitive problems

Neurocognitive impairment linked to prior low CD4 cell count, even if on current suppressive HIV treatment

News
26 July 2010
Starting treatment

CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level

News
23 July 2010
Starting treatment

Lopinavir/ritonavir plus raltegravir NRTI-sparing regimen as effective as traditional HAART

News
20 July 2010
Epidemiology

Newer HIV drugs cost-effective for Africa

News
20 July 2010
Treatment guidelines

Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti

Editor's pick
New England Journal of Medicine
14 July 2010